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Abstract 
 
Background: To detect the presence of keratin in 
apparently non-keratinizing squamous cell carcinomas by 
immunoperoxidase staining. This is important because 
keratinizing tumours are less radiosensitive and non-
keratinizing are more radio responsive. 
Methods: This prospective study was conducted at 
King Edward Medical College and Post Graduate Medical 
Institute, Lahore  over six months, A total of 45 patients 
suffering from squamous cell carcinomas of skin were 
included in the study.Both H and E and 
immunoperoxidase stainings were performed. Positive and 
negative controls were set up. The results of both types of 
staining were compared for each case. 
Results: Four groups were identified. Nineteen cases 
showed obvious keratinization on both H and E and 
immunoperoxidase staining.Eight cases had doubtful 
keratinization on H and E but showed more obvious 
keratinization on immunoperoxidase staining. Seven cases 
were non-keratinizing on H and E staining but revealed 
keratin on immunoperoxidase analysis.Eleven cases were 
non-keratinizing on H and E as well as on 
immunoperoxidase analysis. 
Conclusion: Immunohistological technique can help 
us in revising and modifying our H and E impression of a 
squamous cell carcinoma. It can help us in better diagnosis 
of squamous cell cancers on basis of keratinization.  
Key words: Squamous Cell Carcinoma, Keratinization, 
Immunoperoxidase study. 
 
Introduction 
 
Squamous cell carcinoma is defined as a 
tumour in which cells may resemble any or all of the 
layers of stratified squamous epithelium1,2. 
Keratinization is an important feature of squamous 
cell carcinoma. Stratified squamous epithelium is 
traditionally associated with keratin3. During 
neoplastic transformation there are no major changes 
in the synthesis of the intermediate filament proteins 
by the malignant cells. Thus a well differentiated 
squamous cell carcinoma shows abundant 
keratinization4. On the other hand keratinization is 
almost completely absent in poorly differentiated 
tumours5. 
Immunohistochemistry can be used to localize 
cytokeratin in difficult cases. Immunoperoxidase 
staining with anti-keratin antibodies shows that : a) 
Well differentiated squamous cell carcinomas stain 
intensely with anti-keratin antibodies. b) Moderately 
differentiated tumors show intermediate staining 
intensity. c)  Poorly differentiated tumors reveal weak 
staining6,7.Squamous cell carcinomas are 
radiosensitive8,9. 
 Previously it was thought that there are 19 
distinct types of cytokeratins but latest research shows 
that there are much more cytokeratin types10. Keratin 
was isolated from human callus using the salt 
extraction method of sun and green. Stratum corneum 
obtained from the sole of the human foot was purified. 
In 1975, Kohler and Milstein11 developed 
monoclonal antibodies. In 1982 a monoclonal 
antikeratin antibody AE1 was developed. Spagnolo12 
showed that all carcinomas with the exception of 
hepatocellular, adrenocortical and basal cell 
carcinomas and occasional renal cell and pulmonary 
anaplastic carcinomas reacted with AE1 antibody 
irrespective of differentiation. Later Klein-Szanto13 
showed that AE1 keratin antibody reacts with the 
acidic keratin species of 40K, 48K, 50K, 54K and 56.5K. 
They also described a monoclonal antibody AE3. 
Immunohistological staining for keratin is important 
as keratinizing tumors are less radiosensitive and non 
keratinizing are more radio responsive14. 
Immunostaining for localization of keratin would help 
the oncologist in selection of a correct therapeutic 
regime and prognostic evaluation of the patients. 
The present study was undertaken to compare 
the results of hematoxylin eosin staining and 
immunohistochemical staining for detection of keratin 
in squamous cell carcinomas of skin. 
 
Patients  and Methods 
 
 A total of 45 patients suffering from 
squamous cell carcinoma of skin were included in the 
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study. They were collected from the   Radiotherapeutic 
units of Mayo Hospital and Services Hospital Lahore. 
The patients included in the study belonged to 
both sexes, and all age groups. A detailed history was 
taken and clinical examination carried out on all 
patients. Clinical proforma was filled with special 
reference to age, sex and presenting complaints. In 
most cases biopsy was taken before the initiation of 
radiotherapeutic treatment. Tissue specimen was 
taken by punch biopsy in majority of patients. 
Haematoxylin and Eosin Staining and 
Immunoperoxidase Staining for Cytokeratin were 
done. Biotin-streptAvidin Amplified system was used. 
Cytokertain Polyclonal Antibody commercially 
prepared by Biogenex Laboratories, USA was used. 
After blocking endogenous enzyme and non 
specific protein binding sites in the tissue, a 3 step 
labelling method was used. The sections were 
sequentially treated with the following antibodies: 
i) Primary Antibody: Antibody type, 
Polyclonal. Raised in, Rabbit. Immunogen, 
Cytokeratin. ii) Linking Antibody iii) Labelling 
Antibody The antibody was in the ready to use form. 
Positive controls comprised normal human 
skin and sections from well-differentiated keratinizing 
squamous cell carcinoma, skin. Sections cut from 
lymphomas and fibrosarcomas were used as negative 
controls. With each staining run a slide cut from a well 
differentiated squamous cell carcinoma was used.  
The relative intensity of cytokeratin staining 
was arbitrarily graded as follows: Negative 0, Weakly 
Positive +1, Moderately Positive ++2, Strongly Positive 
+++3, Very Strongly Positive ++++4. 
Positive staining was seen as reddish brown 
keratin antikeratin deposits. 
 
Results 
Of the total 45 cases, 26 (57.8%)were male and 19(42.2%) 
were female. Analysis of tumour size showed that the  
majority of the patients, 30 (66.7%)had large tumour size 
that is 2-5cm. 
Majority  of patients fell in the range of 41 to 
50 years, that is 16(35.5%). Second commonest age 
group was 51 to 60 comprising 11(24.4%) patients. 
Eight (17.8%) were aged between 31 to 40 , six (13.3%) 
between 61 to 70 and two each (4.4%) in the 21 to30 
and 71 to 80 year age group 
Maximum number of patients belonged to the 
well differentiated group. Next commonest was poorly 
differentiated and least common was moderately 
differentiated squamous cell carcinoma. (Fig 1). 
1. Cases which showed obvious keratinization on both 
H&E and immunoperoxidase staining were 19 (42.2%). 
2. Cases which showed doubtful keratinization on 
H&E staining but revealed more obvious keratini-
zation on immunoperoxidase staining were 8 (17.8%). 
3. Cases which were non-keratinizing on H&E staining 
but showed keratinization on immunoperoxidase 
analysis  were 7(15.5%). 
 
 
 
 
 
 
 
  
 
Fig 1: Histological types of Squamous cell CA. 
 
4. Cases which were non-keratinizing on H&E as well 
as on immunoperoxidase analysis were 11 (24.4%). 
 
Discussion 
 
Our study shows well differentiated 
squamous cell carcinoma to be the major histological 
type. This is similar to the work done by Wu et al 15 in 
Chinese population. Poorly differentiated cases 
comprised the second commonest group. The 
relatively large proportion of poorly differentiated 
tumours could be due to inadequate health education 
and incomplete awareness among our masses.  
 There is a male preponderance in our study. 
This is similar to the work done by others. 16-17 Cady 
and Catlin18 did a twenty year survey on epidermoid 
cancer of the gum. Three quarters of the patients were 
males, again pointing to a higher male to female ratio 
in the West.   
The maximum number of our patients were in 
the age range of 40-60 year. Gal et al showed an age 
range of 49-82 years19. Another study by Elman et al 
also showed an age range from 46-81 years.20 Thus our 
patients belonged to a younger age group as compared 
to the western countries. In the well-differentiated 
tumours keratin antikeratin complexes were abundant. 
All the horn pearls were stained positive. The 
connective tissue and the vessels did not stain. This is 
similar to the results of Said et al .21  
In well differentiated squamous cell carcinoma 
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staining positivity is 100%. This is comparable with the 
work done by Robinson and Gottschalk22.Tumours of 
moderate differentiation showed much less staining 
positivity as also seen by Corson et al 23. In the poorly 
differentiated tumours staining reaction was weak or 
focally positive. There were some cases, which did not 
stain at all. This is similar to the results of others5. 
Our study helped in revising the original HE 
impression in 33.3% of patients. These included 
patients who showed doubtful keratinization on HE 
staining but revealed obvious keratinization on 
Immunoperoxidase staining, and patients who 
showed non keratinizing tumours on HE but showed 
keratin on Immunohistological analysis. Researchers24 
have  also commented that immuno-staining 
confirmed, modified or in several instances, changed 
the original light microscopic impression. In 33.3% of 
the cases we gave revised diagnosis and this helped 
the oncologist in selection of a correct therapeutic 
regime and better prognostic evaluation of the 
patients.   
In conclusion, cytokeratin is highly valuable in 
differentiating apparently non-keratinizing squamous 
cell carcinomas from the keratinizing squamous cell 
carcinomas. Thus the immunoperoxidase technique 
can help us in revising and modifying  our original H 
and E impression. Cytokeratin is an epithelial cell 
marker which can be very well used as a tumour 
marker for squamous cell carcinoma of skin. 
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